Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Thomas

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Reply to Yan et alAnish Thomas
Expert Review of Anticancer Therapy|May 24, 2016
Should anti-mesothelin therapies be explored in lung cancer?Anish Thomas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Targeting Topoisomerase I in the Era of Precision MedicineAnish Thomas, Yves Pommier
The Lancet. Oncology|July 4, 2012
Immunotherapies for non-small-cell lung cancer and mesotheliomaAnish Thomas, Raffit Hassan
The Lancet. Oncology|July 22, 2017
CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?Anish Thomas, Raffit Hassan
JAMA Network Open|April 20, 2026
Incidence, Mortality, and Federal Research Funding by Cancer Type in the USChirayu Mohindroo, Anish Thomas
The Lancet. Oncology|June 6, 2020
Lenvatinib for thymic carcinomasNobuyuki Takahashi, Anish Thomas
Science Translational Medicine|July 8, 2016
Small cell lung cancer: Time to revisit DNA-damaging chemotherapyAnish Thomas, Yves Pommier
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 13, 2008
Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adultAnish Thomas, Robert Lenox
Expert Opinion on Biological Therapy|June 1, 2014
Immunotherapy for non-small-cell lung cancerAnish Thomas, Marko Jakopovic
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Reply to Yan et alAnish Thomas
Expert Review of Anticancer Therapy|May 24, 2016
Should anti-mesothelin therapies be explored in lung cancer?Anish Thomas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Targeting Topoisomerase I in the Era of Precision MedicineAnish Thomas, Yves Pommier
The Lancet. Oncology|July 4, 2012
Immunotherapies for non-small-cell lung cancer and mesotheliomaAnish Thomas, Raffit Hassan
The Lancet. Oncology|July 22, 2017
CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?Anish Thomas, Raffit Hassan
JAMA Network Open|April 20, 2026
Incidence, Mortality, and Federal Research Funding by Cancer Type in the USChirayu Mohindroo, Anish Thomas
The Lancet. Oncology|June 6, 2020
Lenvatinib for thymic carcinomasNobuyuki Takahashi, Anish Thomas
Science Translational Medicine|July 8, 2016
Small cell lung cancer: Time to revisit DNA-damaging chemotherapyAnish Thomas, Yves Pommier
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 13, 2008
Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adultAnish Thomas, Robert Lenox
Expert Opinion on Biological Therapy|June 1, 2014
Immunotherapy for non-small-cell lung cancerAnish Thomas, Marko Jakopovic
Pageof 17